Stay updated on AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly
Sign up to get notified when there's something new on the AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly page.

Latest updates to the AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRemoved Napoli, Italy, 80131 and added Naples, Italy, 80131.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision history updated to include v3.5.0 and remove v3.4.3.SummaryDifference0.0%

- Check22 days agoChange DetectedThe page revision updated to v3.4.3, replacing the previous v3.4.2. This appears to be a metadata update with no visible changes to study details or user-facing content.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded site revision tag: Revision: v3.4.2. Removed prior maintenance notices referencing Revision: v3.4.1 (funding status and operating status).SummaryDifference0.3%

- Check58 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the software revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check65 days agoChange DetectedUpdates add a glossary toggle, display the 'Last Update Submitted that Met QC Criteria' field, and change the revision label from v3.3.4 to v3.4.0. Minor capitalization changes to 'No FEAR Act Data' are also applied.SummaryDifference0.2%

Stay in the know with updates to AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly
Enter your email address, and we'll notify you when there's something new on the AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly page.